Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 22

1.

Factors Affecting Hemoglobin A1C in the Diagnosis of Diabetes and Prediabetes in Youth.

Hitt JM, Velasquez-Mieyer P, Neira C, Cowan P.

J Pediatr Nurs. 2016 Sep-Oct;31(5):511-8. doi: 10.1016/j.pedn.2016.03.020.

PMID:
27132801
2.

Prediabetes and blood pressure effects on heart rate variability, QT-interval duration, and left ventricular hypertrophy in overweight-obese adolescents.

Lee S, Cowan PA, Wetzel GT, Velasquez-Mieyer P.

J Pediatr Nurs. 2011 Oct;26(5):416-27. doi: 10.1016/j.pedn.2010.08.008.

PMID:
21930028
3.

A pilot study of QT interval analysis in overweight and obese youth.

Lee S, Cowan PA, Velasquez-Mieyer P.

Appl Nurs Res. 2012 Aug;25(3):218-21. doi: 10.1016/j.apnr.2010.11.003.

4.

Calcium intake and body composition in African-American children and adolescents at risk for overweight and obesity.

Tylavsky FA, Cowan PA, Terrell S, Hutson M, Velasquez-Mieyer P.

Nutrients. 2010 Sep;2(9):950-64. doi: 10.3390/nu2090950.

5.

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial.

Bergenstal RM, Wysham C, Macconell L, Malloy J, Walsh B, Yan P, Wilhelm K, Malone J, Porter LE; DURATION-2 Study Group..

Lancet. 2010 Aug 7;376(9739):431-9. doi: 10.1016/S0140-6736(10)60590-9.

PMID:
20580422
6.

Longitudinal study of muscle strength, quality, and adipose tissue infiltration.

Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, Boudreau R, Manini TM, Nevitt M, Newman AB, Goodpaster BH; Health, Aging, and Body..

Am J Clin Nutr. 2009 Dec;90(6):1579-85. doi: 10.3945/ajcn.2009.28047.

7.

The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.

Neira CP, Hartig M, Cowan PA, Velasquez-Mieyer PA.

J Am Acad Nurse Pract. 2009 Mar;21(3):173-8. doi: 10.1111/j.1745-7599.2008.00380.x.

PMID:
19302694
8.

Assessing the risk of impaired glucose metabolism in overweight adolescents in a clinical setting.

Velasquez-Mieyer PA, Cowan PA, Neira CP, Tylavsky F.

J Nutr Health Aging. 2008 Dec;12(10):750S-757S.

PMID:
19043652
9.

Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus.

Velásquez-Mieyer PA, Neira CP.

Expert Opin Pharmacother. 2008 Sep;9(13):2377-82. doi: 10.1517/14656566.9.13.2377 . Review.

PMID:
18710361
10.

Perceived barriers and facilitators to physical activity in kidney transplant recipients.

Sánchez ZV, Cashion AK, Cowan PA, Jacob SR, Wicks MN, Velasquez-Mieyer P.

Prog Transplant. 2007 Dec;17(4):324-31.

PMID:
18240699
11.

Racial disparity in glucagon-like peptide 1 and inflammation markers among severely obese adolescents.

Velásquez-Mieyer PA, Cowan PA, Pérez-Faustinelli S, Nieto-Martínez R, Villegas-Barreto C, Tolley EA, Lustig RH, Alpert BS.

Diabetes Care. 2008 Apr;31(4):770-5. doi: 10.2337/dc07-1525.

PMID:
18184905
12.

Obesity and cardiometabolic syndrome in children.

Velasquez-Mieyer P, Neira CP, Nieto R, Cowan PA.

Ther Adv Cardiovasc Dis. 2007 Oct;1(1):61-81. doi: 10.1177/1753944707082800. Review.

PMID:
19124396
13.

Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.

Harden KA, Cowan PA, Velasquez-Mieyer P, Patton SB.

J Am Acad Nurse Pract. 2007 Jul;19(7):368-77.

PMID:
17680902
14.

Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children.

Lustig RH, Mietus-Snyder ML, Bacchetti P, Lazar AA, Velasquez-Mieyer PA, Christensen ML.

J Pediatr. 2006 Jan;148(1):23-9.

15.

Single- and multiple-dose pharmacokinetics of pioglitazone in adolescents with type 2 diabetes.

Christensen ML, Meibohm B, Capparelli EV, Velasquez-Mieyer P, Burghen GA, Tamborlane WV.

J Clin Pharmacol. 2005 Oct;45(10):1137-44.

PMID:
16172178
16.

A multicenter, randomized, double-blind, placebo-controlled, dose-finding trial of a long-acting formulation of octreotide in promoting weight loss in obese adults with insulin hypersecretion.

Lustig RH, Greenway F, Velasquez-Mieyer P, Heimburger D, Schumacher D, Smith D, Smith W, Soler N, Warsi G, Berg W, Maloney J, Benedetto J, Zhu W, Hohneker J.

Int J Obes (Lond). 2006 Feb;30(2):331-41.

17.

Obesity, leptin resistance, and the effects of insulin reduction.

Lustig RH, Sen S, Soberman JE, Velasquez-Mieyer PA.

Int J Obes Relat Metab Disord. 2004 Oct;28(10):1344-8.

PMID:
15314628
18.

Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults.

Velasquez-Mieyer PA, Umpierrez GE, Lustig RH, Cashion AK, Cowan PA, Christensen M, Spencer KA, Burghen GA.

Int J Obes Relat Metab Disord. 2004 Feb;28(2):330-3.

19.

Type 2 diabetes mellitus in children and adolescents: the new challenge.

Christensen ML, Rashed SM, Sinclair J, Cowan PA, Velasquez-Mieyer P, Burghen GA.

J Pediatr Pharmacol Ther. 2004 Jan;9(1):15-26. doi: 10.5863/1551-6776-9.1.15.

20.

Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects.

Velasquez-Mieyer PA, Cowan PA, Umpierrez GE, Lustig RH, Cashion AK, Burghen GA.

Int J Obes Relat Metab Disord. 2003 Nov;27(11):1359-64.

Items per page

Supplemental Content

Loading ...
Support Center